Clinical Trial
[Acebutolol in the treatment of arterial hypertension. Clinical study]
[Article in
French]
- PMID: 768911
Item in Clipboard
Clinical Trial
[Acebutolol in the treatment of arterial hypertension. Clinical study]
[Article in
French]
Nouv Presse Med.
.
Abstract
Fifty hypertensive patients were given a beta-blocker, acebutolol, alone or in association with other hypotensive drugs, in an open therapeutic trial lasting for a year. The results of treatment were considered to be good or moderate in 74 p.cent of the patients. Treatment failures were recorded in 26 p.cent. The mean dosage of acebutolol was 10 mg/kg (maximum 22 mg/kg) and the drug was very well tolerated. Hypertension with an increased cardiac index and reno-vascular hypertension with increased plasma renin activity are good indications for acebutolol.
Similar articles
-
[Treatment of arterial hypertension with acebutolol. Double-blind study with placebos].Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3273-7. Nouv Presse Med. 1975. PMID: 1219635 Clinical Trial. French.
-
[Test with trinitrine. Clinical evaluation of the beta anti-adrenergic effect of acebutolol in arterial hypertension].Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3257-59. Nouv Presse Med. 1975. PMID: 815887 Clinical Trial. French.
-
[Acebutolol test in moderate arterial hypertension. Action on systolic time intervals].Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3268-72. Nouv Presse Med. 1975. PMID: 768908 Clinical Trial. French.
-
Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.Postgrad Med J. 1983;59 Suppl 3(689):140-58. Postgrad Med J. 1983. PMID: 6139800 Free PMC article. Review.
-
Acebutolol: ten years of experience.Am Heart J. 1985 May;109(5 Pt 2):1211-3. doi: 10.1016/0002-8703(85)90712-4. Am Heart J. 1985. PMID: 2859785 Review.